172 related articles for article (PubMed ID: 30724098)
1. Resolvin D1 attenuates mechanical stretch-induced pulmonary fibrosis via epithelial-mesenchymal transition.
Yang Y; Hu L; Xia H; Chen L; Cui S; Wang Y; Zhou T; Xiong W; Song L; Li S; Pan S; Xu J; Liu M; Xiao H; Qin L; Shang Y; Yao S
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1013-L1024. PubMed ID: 30724098
[TBL] [Abstract][Full Text] [Related]
2. Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition.
Cabrera-Benítez NE; Parotto M; Post M; Han B; Spieth PM; Cheng WE; Valladares F; Villar J; Liu M; Sato M; Zhang H; Slutsky AS
Crit Care Med; 2012 Feb; 40(2):510-7. PubMed ID: 21926573
[TBL] [Abstract][Full Text] [Related]
3. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
Lee HJ; Park MK; Lee EJ; Lee CH
Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
[TBL] [Abstract][Full Text] [Related]
4. RvD1 ameliorates LPS-induced acute lung injury via the suppression of neutrophil infiltration by reducing CXCL2 expression and release from resident alveolar macrophages.
Zhang HW; Wang Q; Mei HX; Zheng SX; Ali AM; Wu QX; Ye Y; Xu HR; Xiang SY; Jin SW
Int Immunopharmacol; 2019 Nov; 76():105877. PubMed ID: 31522017
[TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways.
Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H
J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840
[TBL] [Abstract][Full Text] [Related]
6. Mechanical Stress and the Induction of Lung Fibrosis via the Midkine Signaling Pathway.
Zhang R; Pan Y; Fanelli V; Wu S; Luo AA; Islam D; Han B; Mao P; Ghazarian M; Zeng W; Spieth PM; Wang D; Khang J; Mo H; Liu X; Uhlig S; Liu M; Laffey J; Slutsky AS; Li Y; Zhang H
Am J Respir Crit Care Med; 2015 Aug; 192(3):315-23. PubMed ID: 25945397
[TBL] [Abstract][Full Text] [Related]
7. 17(R)-resolvin D1 ameliorates bleomycin-induced pulmonary fibrosis in mice.
Yatomi M; Hisada T; Ishizuka T; Koga Y; Ono A; Kamide Y; Seki K; Aoki-Saito H; Tsurumaki H; Sunaga N; Kaira K; Dobashi K; Yamada M; Okajima F
Physiol Rep; 2015 Dec; 3(12):. PubMed ID: 26660549
[TBL] [Abstract][Full Text] [Related]
8. Maresin 1 Inhibits Epithelial-to-Mesenchymal Transition in Vitro and Attenuates Bleomycin Induced Lung Fibrosis in Vivo.
Wang Y; Li R; Chen L; Tan W; Sun Z; Xia H; Li B; Yu Y; Gong J; Tang M; Ji Y; Yuan S; Shanglong Yao ; Shang Y
Shock; 2015 Nov; 44(5):496-502. PubMed ID: 26196843
[TBL] [Abstract][Full Text] [Related]
9. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
10. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
[TBL] [Abstract][Full Text] [Related]
11. Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury.
Wang Q; Zheng X; Cheng Y; Zhang YL; Wen HX; Tao Z; Li H; Hao Y; Gao Y; Yang LM; Smith FG; Huang CJ; Jin SW
J Immunol; 2014 Apr; 192(8):3765-77. PubMed ID: 24646745
[TBL] [Abstract][Full Text] [Related]
12. Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.
Liu GJ; Tao T; Wang H; Zhou Y; Gao X; Gao YY; Hang CH; Li W
J Neuroinflammation; 2020 Aug; 17(1):239. PubMed ID: 32795323
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inflammasome Activation Contributes to Mechanical Stretch-Induced Endothelial-Mesenchymal Transition and Pulmonary Fibrosis.
Lv Z; Wang Y; Liu YJ; Mao YF; Dong WW; Ding ZN; Meng GX; Jiang L; Zhu XY
Crit Care Med; 2018 Jan; 46(1):e49-e58. PubMed ID: 29088003
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D1 attenuates ventilator-induced lung injury by reducing HMGB1 release in a HO-1-dependent pathway.
Sun Z; Wang F; Yang Y; Wang J; Sun S; Xia H; Yao S
Int Immunopharmacol; 2019 Oct; 75():105825. PubMed ID: 31437789
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
16. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.
Krishnamoorthy S; Recchiuti A; Chiang N; Fredman G; Serhan CN
Am J Pathol; 2012 May; 180(5):2018-27. PubMed ID: 22449948
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-19b Mediates Lung Epithelial-Mesenchymal Transition via Phosphatidylinositol-3,4,5-Trisphosphate 3-Phosphatase in Response to Mechanical Stretch.
Mao P; Li J; Huang Y; Wu S; Pang X; He W; Liu X; Slutsky AS; Zhang H; Li Y
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):11-19. PubMed ID: 27508324
[TBL] [Abstract][Full Text] [Related]
18. Resolvin D1 Prevents Epithelial-to-Mesenchymal Transition and Reduces Collagen Deposition by Stimulating Autophagy in Intestinal Fibrosis.
Zeng C; Liu X; Xiong D; Zou K; Bai T
Dig Dis Sci; 2022 Oct; 67(10):4749-4759. PubMed ID: 35013877
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory actions of aspirin-triggered resolvin D1 (AT-RvD1) in bronchial epithelial cells stimulated by cigarette smoke extract.
de Oliveira JR; Pereira ABM; de Souza HI; Dos Santos WM; de Assunção TSF; de Vito FB; de Souza HM; da Silva PR; da Silva MV; Junior VR; Rogerio AP
Prostaglandins Other Lipid Mediat; 2024 Jun; 172():106833. PubMed ID: 38460760
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
